Increased Gal-1 has however been associated with worse prognosis in other interstitial lung disease (ILD) (d’Alessandro et al., 2020) and COVID-19 induced inflammation (Markovic et al., 2022). The gene discussed is LGALS1; the disease is COVID-19.